News
Pharma logistics specialist Medexi to open Pharma Center at Brussels Airport
Brussels Airport continues to invest in its logistics zone Brucargo, where it took delivery of a new building accommodating 4,000m² of warehousing and office space. The building will become the home base of Medexi, a joint venture by several...
News
RedHill Biopharmas opaganib shows activity against Covid-19 variants
RedHill Biopharma has reported initial findings from a preclinical study, which revealed that its drug candidate, opaganib (Yeliva, ABC294640), could block Covid-19 variants of concern.
Opaganib is an investigational host-targeted oral drug being developed to treat Covid-19. With antiviral and...
News
Lonza Invests CHF 20 million to Expand API Development and Manufacturing Facility in Nansha, China
Lonza announced new investments in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China. The investments, totaling over CHF 20 million, will allow Lonza to provide a smoother transition from small-scale to large-scale manufacturing...
News
Building authentication eco-systems is crucial to prevent falsified medicines; must implement export measures for domestic market : Experts at The Authentication Forum webinar
Held on 11 June, ASPA and Messe Frankfurt India united senior leaders and industry experts for a panel discussion on “Protecting the lives and pharmaceutical supply chain during COVID-19” at The Authentication Forum webinar. Setting up an authentication &...
News
Catalent to Acquire RheinCell Therapeutics, Strengthening a Path Towards Industrialization of Induced Pluripotent Stem Cell-based Therapies
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, announced that it has reached an agreement to acquire RheinCell Therapeutics GmbH, a developer and...
Clinical Trials
Tiziana and FHI Clinical work on Phase II intranasal Covid-19 drug trial
Tiziana Life Sciences plc, a biotechnology company focused on innovative therapeutics for oncology, neurology, inflammation and infectious diseases, announces that it has signed an agreement with FHI Clinical, a global clinical contract research organization (CRO), to conduct a Phase...
News
Metrics Contract Services Increases Capacity With New Equipment Investment
Metrics Contract Services, the contract pharmaceutical development and manufacturing division of Mayne Pharma, has invested in additional equipment to enhance capacity in drug delivery. A Korsch XM-12 Bilayer Tablet Press and a Top Spray Fluidization system for the Glatt...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read